Grown Rogue International (GRUSF) Revenue Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 40.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.75% |
| Mar 31, 2026 | 28.05% |
| Dec 31, 2025 | -61,976,161.19% |
| Sep 30, 2025 | 104,632,296.30% |
| Jun 30, 2025 | 98,520,228,397,318.12% |
| Mar 31, 2025 | 7.45% |
| Dec 31, 2024 | 631.77% |
| Jan 31, 2023 | 21.37% |
| Jan 31, 2022 | 255.10% |
| Oct 31, 2021 | 255.83% |
| Jul 31, 2021 | 235.07% |
| Apr 30, 2021 | 31.20% |
| Jan 31, 2021 | -4.98% |
| Oct 31, 2020 | 144.82% |
| Jul 31, 2020 | 16.81% |
| Apr 30, 2020 | -37.80% |
| Jan 31, 2020 | 32.60% |
| Oct 31, 2019 | -45.38% |
| Jul 31, 2019 | 13.83% |
| Apr 30, 2019 | 547.75% |